UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Holdings in GE HealthCare Technologies Inc. $GEHC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.8% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 2,541,393 shares of the company’s stock after acquiring an additional 20,180 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in GE HealthCare Technologies were worth $162,675,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of GEHC. Western Wealth Management LLC boosted its stake in shares of GE HealthCare Technologies by 2.4% in the fourth quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock worth $430,000 after buying an additional 125 shares during the last quarter. Parkside Financial Bank & Trust raised its position in GE HealthCare Technologies by 3.9% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,567 shares of the company’s stock valued at $293,000 after acquiring an additional 134 shares in the last quarter. Quadrant Capital Group LLC raised its position in GE HealthCare Technologies by 1.1% during the fourth quarter. Quadrant Capital Group LLC now owns 12,557 shares of the company’s stock valued at $1,030,000 after acquiring an additional 140 shares in the last quarter. Mount Vernon Associates Inc. MD lifted its holdings in GE HealthCare Technologies by 0.8% in the first quarter. Mount Vernon Associates Inc. MD now owns 18,165 shares of the company’s stock valued at $1,293,000 after acquiring an additional 144 shares during the period. Finally, Norinchukin Bank The boosted its position in GE HealthCare Technologies by 0.4% in the 3rd quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock worth $2,922,000 after purchasing an additional 149 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 1.1%

Shares of GEHC stock opened at $70.42 on Wednesday. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The company has a market cap of $31.81 billion, a price-to-earnings ratio of 16.15, a PEG ratio of 1.88 and a beta of 0.70. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.26 and a quick ratio of 0.97. The stock has a 50 day simple moving average of $68.02 and a 200-day simple moving average of $69.14.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.04 by $0.09. The firm had revenue of $5.29 billion for the quarter, compared to analysts’ expectations of $5.26 billion. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the company earned $1.06 EPS. On average, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.93 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Friday, July 24th were given a $0.035 dividend. The ex-dividend date was Friday, July 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.21%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on GEHC. Evercore reaffirmed an “outperform” rating and set a $84.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. BTIG Research reissued a “buy” rating and set a $79.00 price target on shares of GE HealthCare Technologies in a report on Wednesday, August 19th. UBS Group raised their price target on shares of GE HealthCare Technologies from $67.00 to $73.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. BMO Capital Markets began coverage on shares of GE HealthCare Technologies in a report on Wednesday, July 8th. They issued a “market perform” rating and a $70.00 price objective for the company. Finally, The Goldman Sachs Group reiterated a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. Ten research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $77.73.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.